Concurrent and Adjuvant PD1 Treatment Combined With Chemo-radiotherapy for High-risk Nasopharyngeal Carcinoma
Concurrent and Adjuvant PD1 Treatment Combined With Chemo-radiotherapy for High-risk Nasopharyngeal Carcinoma
Recruiting · NCT04453826 · Registry updated 2020-09-28Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Concurrent and Adjuvant PD1 Treatment Combined With Chemo-radiotherapy for High-risk Nasopharyngeal Carcinoma | Head and Neck Neoplasms, Neoplasms by Site, Otorhinolaryngologic Neoplasms, Pharyngeal Diseases, Stomatognathic Diseases, malignant tumor of nasopharynx, nasopharyngeal disorder, nasopharyngeal neoplasm, neoplasm, otorhinolaryngologic disease | Recruiting | Phase 3 | 2020-09-28 | NCT04453826 |
6 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cancer Center of Guangzhou Medical University | Guangzhou | China | 3 |
| Sun Yat-sen University Cancer Center | Guangzhou | China | 315 |
| The Fifth Affiliated Hospital of Sun Yat-sen University | Zhuhai | China | 21 |
| Wuzhou Red Cross Hospital | Wuzhou | China | 14 |
| Yuebei People's Hospital | Shaoguan | China | 3 |
| Zhongshan People's Hospital | Zhongshan | China | 14 |